CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-26 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −22,545 | 45,088 | ||
| 2022-02-26 | KIES PETER CFO | Grant or award · Common Stock Option | +192,800 | 192,800 | ||
| 2022-02-26 | KIES PETER CFO | Grant or award · Restricted Stock Unit | +143,900 | 143,900 | ||
| 2022-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise | +22,545 | 91,132 | ||
| 2022-02-26 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −8,545 | $3.22 | $28K | 82,587 |
| 2022-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −22,545 | 45,088 | ||
| 2022-02-26 | Humeau Laurent Chief Scientific Officer | Grant or award · Common Stock Option | +186,000 | 186,000 | ||
| 2022-02-26 | Humeau Laurent Chief Scientific Officer | Grant or award · Restricted Stock Unit | +138,800 | 138,800 | ||
| 2022-02-26 | Shea Jacqueline Elizabeth Chief Operating Officer | Option exercise | +22,545 | 44,137 | ||
| 2022-02-26 | Shea Jacqueline Elizabeth Chief Operating Officer | Shares withheld for taxes | −10,764 | $3.22 | $35K | 33,373 |
| 2022-02-26 | Shea Jacqueline Elizabeth Chief Operating Officer | Option exercise · Restricted Stock Unit | −22,545 | 45,088 | ||
| 2022-02-26 | Shea Jacqueline Elizabeth Chief Operating Officer | Grant or award · Common Stock Option | +282,300 | 282,300 | ||
| 2022-02-26 | Shea Jacqueline Elizabeth Chief Operating Officer | Grant or award · Restricted Stock Unit | +210,700 | 210,700 | ||
| 2022-02-26 | Kim Jong Joseph Chief Executive Officer | Option exercise | +68,767 | 1,297,425 | ||
| 2022-02-26 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −20,045 | $3.22 | $65K | 1,277,380 |
| 2022-02-26 | Kim Jong Joseph Chief Executive Officer | Option exercise · Restricted Stock Unit | −68,767 | 137,533 | ||
| 2022-02-26 | Kim Jong Joseph Chief Executive Officer | Grant or award · Common Stock Option | +627,700 | 627,700 | ||
| 2022-02-26 | Kim Jong Joseph Chief Executive Officer | Grant or award · Restricted Stock Unit | +468,500 | 468,500 | ||
| 2022-01-19 | BENITO SIMON X Director | Option exercise | +2,000 | $2.20 | $4K | 59,305 |
| 2022-01-19 | BENITO SIMON X Director | Sale | −2,000 | $4.27 | $9K | 57,305 |
Page 21 of 32 · 622 trades